Kane Biotech Announces New Credit Facility
September 02, 2021 08:00 ET
|
Kane Biotech Inc.
WINNIPEG, Manitoba, Sept. 02, 2021 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE; OTCQB:KNBIF), (the “Company” or “Kane Biotech”), today announces that it has entered into an amended and restated...
STEM Animal Health completes first shipment of bluestem™ oral care products to PetSmart® Canada
August 31, 2021 08:00 ET
|
Kane Biotech Inc.
WINNIPEG, Manitoba, Aug. 31, 2021 (GLOBE NEWSWIRE) -- Kane Biotech Inc. announces that STEM Animal Health Inc., has shipped its first order of bluestem™ products to PetSmart® Canada, Canada largest...
Kane Biotech Announces Second Quarter 2021 Financial Results
August 26, 2021 16:00 ET
|
Kane Biotech Inc.
WINNIPEG, Manitoba, Aug. 26, 2021 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”) today announced its Second Quarter 2021 financial results. Second...
Kane Biotech to Release Second Quarter 2021 Financial Results on August 26 – Conference Call to Follow
August 19, 2021 16:00 ET
|
Kane Biotech Inc.
WINNIPEG, Manitoba, Aug. 19, 2021 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”), a biotechnology company engaged in the research, development and...
Kane Biotech Receives Decisions to Grant for Two European Patents Providing Broad Protection of coactiv+™ Technology for Wound Care, Skin Infections and Personal Care Formulations
July 29, 2021 08:00 ET
|
Kane Biotech Inc.
WINNIPEG, Manitoba, July 29, 2021 (GLOBE NEWSWIRE) -- Kane Biotech Inc. announces that it has received two Decisions to Grant from the European Patent Office for patents covering its best-in-class...
Kane Biotech Expands its Wound Care and Surgical Portfolio with a coactiv+TM Antimicrobial Hydrogel
July 22, 2021 08:00 ET
|
Kane Biotech Inc.
WINNIPEG, Manitoba, July 22, 2021 (GLOBE NEWSWIRE) -- Kane Biotech Inc. announces plans to expand its wound care and surgical portfolio with an antimicrobial hydrogel based on its best-in-class...
Kane Biotech Announces Cancellation of Options and Issuance of Restricted Share Units
July 21, 2021 16:30 ET
|
Kane Biotech Inc.
WINNIPEG, Manitoba, July 21, 2021 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE; OTCQB:KNBIF), (the “Company” or “Kane Biotech”), today announces that it has cancelled 8,470,555 stock options of...
Kane Biotech announces two key milestones as DispersinB® wound care project advances towards human clinical trials
July 13, 2021 08:00 ET
|
Kane Biotech Inc.
Development of a novel topical hydrogel formulation of DispersinB® with significantly improved stabilityNew manufacturing partnership with Dow Development Laboratories, LLC for clinical product...
Kane Biotech to meet investors at Whistler 2021 Capital Conference
June 29, 2021 10:00 ET
|
Kane Biotech Inc.
WINNIPEG, Manitoba, June 29, 2021 (GLOBE NEWSWIRE) -- Kane Biotech Inc. will host investor meetings at the 10th Annual Whistler 2021 Capital Conference hosted by Capital Event Management the weekend...
Kane Biotech launches 2021 business update series
June 16, 2021 10:00 ET
|
Kane Biotech Inc.
WINNIPEG, Manitoba, June 16, 2021 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE; OTCQB:KNBIF), (the “Company” or “Kane Biotech”), goes live today with the first of a 5-part “2021 business update”...